-
Oramed Pharma (ORMP) Issues Letter to Shareholders
-
Oramed Pharma (ORMP) Announces JV to Accelerate Development and Commercialization of Oral Insulin
-
H.C. Wainwright Reiterates Neutral Rating on Oramed Pharma (ORMP)
-
Oramed Pharma (ORMP) Issues Letter to Shareholders
-
Oramed Pharma (ORMP) Announces $20M Buy-Back of its Common Stock

